Receptor usage dictates HIV-1 restriction by human TRIM5α in dendritic cell subsets

Nature

Volumn 540, Issue 7633, 2016, Pages 448-452

  Ribeiro, Carla M S ^a   Sarrami Forooshani, Ramin ^a   Setiawan, Laurentia C ^a   Zijlstra Willems, Esther M ^a   Van Hamme, John L ^a   Tigchelaar, Wikky ^a   Van Der Wel, Nicole N ^a   Kootstra, Neeltje A ^a   Gringhuis, Sonja I ^a   Geijtenbeek, Teunis B H ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

LANGERIN; TRIPARTITE MOTIF PROTEIN 5; CARRIER PROTEIN; CD207 PROTEIN, HUMAN; CELL ADHESION MOLECULE; CELL SURFACE RECEPTOR; DC-SPECIFIC ICAM-3 GRABBING NONINTEGRIN; LECTIN; LEUKOCYTE ANTIGEN; MANNOSE BINDING LECTIN; TRIM5 PROTEIN, HUMAN; VIRUS RECEPTOR;

ANATOMY; BIODEGRADATION; CELLS AND CELL COMPONENTS; DISEASE TRANSMISSION; ENZYME ACTIVITY; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNITY; INFECTIOUS DISEASE; PATHOGEN; PRIMATE; PROTEIN;

ARTICLE; AUTOPHAGY; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DENDRITIC CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ASSEMBLY; RNA INTERFERENCE; VIRUS ATTACHMENT; VIRUS TRANSMISSION; CELL LINE; CYTOLOGY; HIV INFECTIONS; HOST PATHOGEN INTERACTION; IMMUNOLOGY; LANGERHANS CELL; METABOLISM; MUCOSAL IMMUNITY; PHYSIOLOGY; TRANSMISSION; VIROLOGY;

HUMAN IMMUNODEFICIENCY VIRUS 1; PRIMATES;

ANTIGENS, CD; AUTOPHAGY; CARRIER PROTEINS; CELL ADHESION MOLECULES; CELL LINE; HIV INFECTIONS; HIV-1; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, MUCOSAL; LANGERHANS CELLS; LECTINS, C-TYPE; MANNOSE-BINDING LECTINS; RECEPTORS, CELL SURFACE; RECEPTORS, HIV;

EID: 85010956304     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature20567     Document Type: Article

References (36)

1. Banchereau, J. et al. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18, 767-811 (2000).
2. Hladik, F. et al. Initial events in establishing vaginal entry and infection by human immunodeficiency virus type-1. Immunity 26, 257-270 (2007).
3. Ribeiro, C. M. S., Sarrami-Forooshani, R. & Geijtenbeek, T. B. H. HIV-1 border patrols: Langerhans cells control antiviral responses and viral transmission. Future Virol. 10, 1231-1243 (2015).
4. Sarrami-Forooshani, R. et al. Human immature Langerhans cells restrict CXCR4-using HIV-1 transmission. Retrovirology 11, 52 (2014).
5. de Witte, L. et al. Langerin is a natural Barrier to HIV-1 transmission by Langerhans cells. Nat. Med. 13, 367-371 (2007).
6. Stremlau, M. et al. The cytoplasmic body component TRIM5 restricts HIV-1 infection in Old World monkeys. Nature 427, 848-853 (2004).
7. Sawyer, S. L., Wu, L. I., Emerman, M. & Malik, H. S. Positive selection of primate TRIM5 identifies a critical species-specific retroviral restriction domain. Proc. Natl Acad. Sci. USA 102, 2832-2837 (2005).
8. Song, B. et al. Retrovirus restriction by TRIM5 variants from Old World and New World primates. J. Virol. 79, 3930-3937 (2005).
9. Sayah, D. M., Sokolskaja, E., Berthoux, L. & Luban, J. Cyclophilin A retrotransposition into TRIM5 explains owl monkey resistance to HIV-1. Nature 430, 569-573 (2004).
10. van den Berg, L. M. et al. Caveolin-1 mediated uptake via Langerin restricts HIV-1 infection in human Langerhans cells. Retrovirology 11, 123 (2014).
11. Stremlau, M. et al. Specific recognition and accelerated uncoating of retroviral capsids by the TRIM5 restriction factor. Proc. Natl Acad. Sci. USA 103, 5514-5519 (2006).
12. Yap, M. W., Nisole, S. & Stoye, J. P. A single amino acid change in the SPRY domain of human Trim5 leads to HIV-1 restriction. Curr. Biol. 15, 73-78 (2005).
13. Ganser-Pornillos, B. K. et al. Hexagonal assembly of a restricting TRIM5 protein. Proc. Natl Acad. Sci. USA 108, 534-539 (2011).
14. de Jong, M. A. et al. Mutz-3-derived Langerhans cells are a model to study HIV-1 transmission and potential inhibitors. J. Leukoc. Biol. 87, 637-643 (2010).
15. Mandell, M. A. et al. TRIM proteins regulate autophagy and can target autophagic substrates by direct recognition. Dev. Cell 30, 394-409 (2014).
16. Fujita, N. et al. Recruitment of the autophagic machinery to endosomes during infection is mediated by ubiquitin. J. Cell Biol. 203, 115-128 (2013).
17. Moreau, K., Ravikumar, B., Renna, M., Puri, C. & Rubinsztein, D. C. Autophagosome precursor maturation requires homotypic fusion. Cell. 146. 303-317. 2011).
18. Gramberg, T. et al. Interactions of LSECtin and DC-SIGN/DC-SIGNR with viral ligands: differential pH dependence, internalization and virion binding. Virology 373, 189-201 (2008).
19. Geijtenbeek, T. B. et al. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell 100, 587-597 (2000).
20. Gringhuis, S. I. et al. HIV-1 exploits innate signaling by TLR8 and DC-SIGN for productive infection of dendritic cells. Nat. Immunol. 11, 419-426 (2010).
21. Blanchet, F. P. et al. Human immunodeficiency virus-1 inhibition of immunoamphisomes in dendritic cells impairs early innate and adaptive immune responses. Immunity 32, 654-669 (2010).
22. Ward, E. M., Stambach, N. S., Drickamer, K. & Taylor, M. E. Polymorphisms in human Langerin affect stability and sugar binding activity. J. Biol. Chem. 281, 15450-15456 (2006).
23. Gringhuis, S. I., den Dunnen, J., Litjens, M., van der Vlist, M. & Geijtenbeek, T. B. Carbohydrate-specific signaling through the DC-SIGN signalosome tailors immunity to Mycobacterium tuberculosis, HIV-1 and Helicobacter pylori. Nat. Immunol. 10, 1081-1088 (2009).
24. Smith, A. L. et al. Leukocyte-specific protein 1 interacts with DC-SIGN and mediates transport of HIV to the proteasome in dendritic cells. J. Exp. Med. 204, 421-430 (2007).
25. Wu, X., Anderson, J. L., Campbell, E. M., Joseph, A. M. & Hope, T. J. Proteasome inhibitors uncouple rhesus TRIM5 restriction of HIV-1 reverse transcription and infection. Proc. Natl Acad. Sci. USA 103, 7465-7470 (2006).
26. Perez-Caballero, D., Hatziioannou, T., Yang, A., Cowan, S. & Bieniasz, P. D. Human tripartite motif 5 domains responsible for retrovirus restriction activity and specificity. J. Virol. 79, 8969-8978 (2005).
27. Stremlau, M., Perron, M., Welikala, S. & Sodroski, J. Species-specific variation in the B30.2(SPRY) domain of TRIM5 determines the potency of human immunodeficiency virus restriction. J. Virol. 79, 3139-3145 (2005).
28. Song, B. et al. The B30.2(SPRY) domain of the retroviral restriction factor TRIM5 exhibits lineage-specific length and sequence variation in primates. J. Virol. 79, 6111-6121 (2005).
29. Shi, J. & Aiken, C. Saturation of TRIM5-mediated restriction of HIV-1 infection depends on the stability of the incoming viral capsid. Virology 350, 493-500 (2006).
30. Kootstra, N. A., Munk, C., Tonnu, N., Landau, N. R. & Verma, I. M. Abrogation of postentry restriction of HIV-1-based lentiviral vector transduction in simian cells. Proc. Natl Acad. Sci. USA 100, 1298-1303 (2003).
31. Arrighi, J. F. et al. DC-SIGN-mediated infectious synapse formation enhances X4 HIV-1 transmission from dendritic cells to T cells. J. Exp. Med. 200, 1279-1288 (2004).
32. Björndal, A. et al. Coreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype. J. Virol. 71, 7478-7487 (1997).
33. Setiawan, L. C. & Kootstra, N. A. Adaptation of HIV-1 to rhTrim5-mediated restriction in vitro. Virology 486, 239-247 (2015).
34. Eng, K. E., Panas, M. D., Karlsson Hedestam, G. B. & McInerney, G. M. A novel quantitative flow cytometry-based assay for autophagy. Autophagy 2010, 6, 634-641.
35. Klionsky, D. J. et al. Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy 8, 445-544 (2012).
36. Chan, L. L. et al. A novel image-based cytometry method for autophagy detection in living cells. Autophagy 8, 1371-1382 (2012).